Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...

Once non-small-cell lung cancer (NSCLC) spreads far and wide ... This non-inherited gene defect can cause something referred to as MET (mesenchymal-epithelial transition) exon 14 or METex14 ...

To confirm their discovery, the researchers analyzed patient samples from lung cancer ... 19 different organs. Cancer cells ...

Cancer remains a leading cause of death globally, with lung cancer being particularly ... like cells (CSCs), cells undergoing epithelial-to-mesenchymal transition (EMT), partial EMT cells, and ...

The phenomenon of epithelial–mesenchymal transition (EMT) has gained attention in the field of cancer biology for its potential contribution to the progression of carcinomas. Tumor EMT is a ...

This study is especially significant in that it successfully demonstrated that suppressing DDX54 in immune-desert lung tumors can overcome immunotherapy resistance and improve treatment outcomes.

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...